BAXStockBaxter International Inc.
Verdicts genuinely change. Free email alert the moment BAX's does — no target price to set, unlike a price alert.
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for BAX — this runs off the critical path so the page paints first. It will appear here on its own.
Revenue by business segment
How BAX’s $11.2B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K. Where a reported segment is broken down further by product, the products are shown under it.
| Segment | Share | Revenue |
|---|---|---|
| Medical Products & Therapies › Infusion Therapies & Technologies | 36.5% | $4.1B |
| Healthcare Systems & Technologies › Care & Connectivity Solutions | 17.0% | $1.9B |
| Pharmaceuticals › Injectables & Anesthesia | 12.0% | $1.4B |
| Medical Products & Therapies › Advanced Surgery | 10.7% | $1.2B |
| Healthcare Systems & Technologies › Front Line Care | 10.3% | $1.2B |
| Pharmaceuticals › Drug Compounding | 10.2% | $1.1B |
| Outside the reportable segments | 3.4% | $381.0M |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2026-02-12 (accession 0001628280-26-007733), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
Shariah-compliant alternatives
Compliant companies in Medical Instruments & Supplies listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ISRGIntuitive Surgical Inc | $132.3B | — |
| ALCAlcon Inc. - Registered Shares | $34.7B | — |
| RMDResmed Inc. | $33.5B | — |
| WSTWest Pharmaceutical Services, Inc. | $23.9B | — |
| COOCooper Companies, Inc. | $14.8B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold BAX
24 of the 219 funds whose filed holdings we currently hold own BAX shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns BAX.
You may already own itWidely held U.S. index funds. If you own one, you own BAX through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | BAX in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.25% | 44% |
| VYM VANGUARD HIGH DIVIDEND YIELD INDEX FUND | 0.05% | 46% |
| SCHB Schwab U.S. Broad Market ETF | 0.02% | 53% |
| SPY | 0.02% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.02% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.02% | 56% |
| IVV iShares Core S&P 500 ETF | 0.02% | 56% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.02% | 54% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.02% | 54% |
| Fund | BAX in fund | Fund compliant by weight |
|---|---|---|
| RAFE PIMCO RAFI ESG U.S. ETF | 0.20% | 50% |
| DFSVX U.S. SMALL CAP VALUE PORTFOLIO | 0.19% | 21% |
| ESML iShares ESG Aware MSCI USA Small-Cap ETF | 0.16% | 40% |
| SPGM State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF | 0.03% | 53% |
| ESGV VANGUARD ESG U.S. STOCK ETF | 0.02% | 56% |
| PSPJX LargeCap S&P 500 Index Fund | 0.02% | 53% |
| CVLC Calvert US Large-Cap Core Responsible Index ETF | 0.02% | 56% |
| TISAX Nuveen S&P 500 Index Fund | 0.02% | 53% |
| XSPI NEOS Boosted S&P 500(R) High Income ETF | 0.02% | 51% |
| JAFEX Total Stock Market Index Trust | 0.01% | 52% |
5 more funds
Sorted by BAX’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names BAX once, so a bond is not counted as the shares; 2 more funds name BAX in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | $1,498M | 4.4% | 2026-09-30 |
| Dodge & Cox | Dodge & Cox | $1,336M | 0.7% | 2026-09-30 |
| Edgar Wachenheim | Greenhaven Associates | $298M | 3.7% | 2026-09-30 |
| First Pacific Advisors | First Pacific Advisors | $185M | 2.2% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $142M | 0.0% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $25M | 0.0% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $13M | 0.0% | 2026-09-30 |
| Israel Englander | Millennium Management | $11M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $11M | 0.1% | 2026-09-30 |
| Mark Hillman | Hillman Capital Management | $5M | 3.5% | 2026-09-30 |
| David Shaw | D. E. Shaw & Co. | $3M | 0.0% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $2M | 0.0% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $1M | 0.0% | 2026-09-30 |
| Caxton Associates | Caxton Associates LLP | $1M | 0.0% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $0M | 0.0% | 2026-09-30 |
| Mairs & Power | Mairs & Power | $0M | 0.0% | 2026-09-30 |
| Tweedy, Browne | Tweedy, Browne Company | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 53.80 | NEUTRAL |
| Stochastic %K (14) | 71.02 | NEUTRAL |
| CCI (20) | 26.75 | NEUTRAL |
| Williams %R (14) | -28.98 | NEUTRAL |
| MACD (12,26,9) | 0.01 | BUY |
| ROC (10) | 1.06 | BUY |
| Momentum (10) | 0.27 | BUY |
| EMA (10) | 25.72 | BUY |
| SMA (10) | 26.00 | SELL |
| EMA (20) | 25.45 | BUY |
| SMA (20) | 25.37 | BUY |
| EMA (30) | 25.25 | BUY |
| SMA (30) | 25.16 | BUY |
| EMA (50) | 24.96 | BUY |
| SMA (50) | 24.55 | BUY |
| EMA (100) | 24.10 | BUY |
| SMA (100) | 24.66 | BUY |
| EMA (200) | 22.06 | BUY |
| SMA (200) | 21.69 | BUY |
About Baxter International Inc.
Healthcare · Medical Instruments & Supplies
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 64 |
| ⏰ 4H | RANGING | 41 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.